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Abstract
Objective Measurement of liver iron concentration is a key
parameter for the management of patients with primary and
secondary haemochromatosis. Magnetic resonance imaging
(MRI) has already demonstrated high accuracy to quantify
liver iron content. To be able to improve the current
management of patients that are found to have iron
overload, we need a reproducible, standardised method that
is, or can easily be made, widely available.
Methods This article discusses the different MRI techni-
ques and models to quantify liver iron concentration that
are currently available and envisaged for the near future
from a realistic perspective.
Results T2 relaxometry methods are more accurate than
signal intensity ratio (SIR) methods and they are reproduc-
ible but are not yet standardised or widely available. SIR
methods, on the other hand, are very specific for all levels
of iron overload and, what is more, they are also
reproducible, standardised and already widely available.
Conclusions For these reasons, today, both methods remain
necessary while progress is made towards universal
standardisation of the relaxometry technique.
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Introduction
Haemochromatosis is themost common cause of iron overload.
In the primary or genetic form, there is excessive absorption of
iron in the intestine, which cannot be eliminated by the body
and accumulates in various organs, causing irreversible
damage. In the secondary form, the surplus iron comes from
multiple blood transfusions or blood disorders, such as
haemolytic anemia or ineffective erythropoiesis, and again
there is progressive accumulation in various organs. In both
forms, the liver and the heart are the most damaged organs.
The process can be reversed through treatment, by phlebot-
omies in primary haemochromatosis cases and using iron-
chelating agents in patients with the secondary form [1, 2].
Indirect markers have been identified, such as serum
ferritin and transferrin saturation, and these are sensitive but
are not specific [3]. Further, the diagnosis of primary
haemochromatosis has improved since various associated
genetic mutations were discovered some years ago. Never-
theless, the key indicator is the measurement of liver iron
concentration (LIC). Haemochromatosis is the only condi-
tion known to be able to cause the LIC to rise to above
80 μmol Fe/g or to twice the age of the patient. In its
secondary form, it generally involves LIC values even
higher than those seen in the primary one.
This is currently an important field: in the case of primary
haemochromatosis because it is being confirmed that genetic
mutations, widely studied in recent years, are not conclusive
for the definitive diagnosis of the disease; and in the secondary
form due to the emergence of new iron chelating agents,
which are changing the clinical management of the disease.
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Chemical analysis of a liver biopsy is the “gold
standard” for the measurement of LIC, but patients are
resistant to this approach as it is invasive and, moreover,
results vary widely: the coefficient of variation in the
quantification obtained by liver biopsy is from 19% in a
healthy liver up to 40% in the case of cirrhosis [4–7]. In this
context, the possibility of having at our disposal, a non-
invasive tool such as magnetic resonance imaging (MRI),
to accurately measure the LIC and thereby assess the need
to treat a patient, as well as monitor their response to any
treatment, represents a great step forward.
MRI-based techniques for assessing LIC can be classi-
fied into signal intensity ratio (SIR) and relaxometry
methods. Various different techniques have been described,
including: (1) relaxometry methods measuring absolute T2;
(2) relaxometry methods measuring T2*, which is also an
absolute value but measured with gradient echo (GRE)
sequences; (3) methods measuring SIR between the liver
and other tissues in which iron is not generally deposited,
usually paraspinal muscles.
For MRI to be able to respond to the current challenges
in clinical practice, it is necessary for there to be a
universally accepted MRI method that is accurate, repro-
ducible, standardised and widely available.
T2 relaxometry methods
Assessment of iron overload is based on decreases in the T2
relaxation times induced in the liver due to the paramagnetic
properties of iron. This acceleration of the T2 relaxation is
proportional to the quantity of iron and leads to a decrease in
the MRI signal intensity (SI) from the liver (Fig. 1).
Relaxometry methods calculate T2 [8, 9] or T2* [10–13]
by fitting a decay models to the average signal intensity at
Fig. 1 T2* transverse relaxation decay curves of signals from the
liver in four theoretical examples with different LIC values. a Liver
without iron overload, at the lower limit of the normal range (T2* =
6.7 ms). b Liver with slight iron overload (T2* = 4.5 ms). c Liver with
high iron overload (T2* = 2 ms). d Liver with very high iron overload
(T2* = 1 ms)
Fig. 2 Multi-echo sequence of two patients with different LICs (TR
21 ms, flip angle 35° (TE first = 1.22 ms, TE interval = 1 ms, 20 echoes).
Acquisition time: 14.5 s; matrix 244/145). a Patient without iron
overload; isointensity of the liver for all the echoes; T2* =17.4 ms. b
Patient with iron overload with loss of the signal from the first echoes;
T2* = 2.1 ms
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various echo times (TEs). These values may also be
expressed as relaxation rates R2 (1/T2) or R2* (1/T2*). To
obtain reliable measurements of T2 at different levels of iron
overload, acquisition sequences with many different TEs are
necessary (Fig. 2). SI is plotted as a function of echo time
and a T2 parametric map is automatically obtained.
Many studies have shown a high correlation of T2 and
T2* values with LIC measured in liver biopsies for the
assessment of all levels of LIC [12, 13] (Fig. 3). Further-
more, it has been confirmed that the technique is reproduc-
ible with different machines. Some mathematical models
have also been developed to transform T2 and T2* values
into LIC values in mg Fe/g [11, 14]. In addition, they allow
the measurement of the iron content in the myocardium,
which is a very important parameter for the management of
patients with secondary haemochromatosis.
However, T2 and T2* relaxometry methods still have
notable limitations. Measurements depend on both the MRI
sequence parameters and the image analysis procedure, and
there is still no consensus concerning which is the most
appropriate MRI technique. Accordingly, to have a repro-
ducibility of measurements it is important that universally
accepted MRI protocols are established.
In particular, there is no general consensus on which index
(R2, R2*) is best for the measurement of LIC [14–16]. For
T2* calculations, GRE sequences are more sensitive to low
iron content but they suffer from inaccuracies at high iron
overload [17]. Christoforidis et al [18] compared two
different MRI models that calculate R2 and R2* respectively,
in a group of 98 patients with thalassemia, and found a lack
of correlation between the two methods.
To minimise the uncertainty in the measured T2, a
relatively large number of echoes is required in order to
sample the entire exponential decay of the transverse
magnetisation. Further, the first TE is key and should be as
short as possible: 5 ms or less for T2 measurements [9, 14]
and 1 ms or less for T2* methods [13, 18]. Hankins et al [13]
compared R2* values to the LIC measured by liver biopsy
using three different MRI methods, finding that the
estimations obtained with the shortest first TE were the most
closely correlated with the directly measured values (Fig. 4).
T2 measurements are also influenced by echo spacing [9].
Fig. 3 R2 and R2* versus LIC measured in liver biopsies. a R2-LIC versus biopsy LIC in 105 patients. “R2 LIC” corresponds to values of LIC
estimated from a calibration equation with R2 values (see [8]). b R2* versus biopsy LIC in 21 patients (r=0.97) (see [11])
Fig. 4 R2* values calculated with three different MRI methods with
respect to the LIC measured in liver biopsies for the same group of
patients. The models of Hankins et al and Wood et al have a better
correlation than the model of Anderson et al The first echo is 2.3 ms
in the Anderson et al model and 1 ms in the other two (see [13])
Table 1 Different GRE sequences with fixed TR and variable TE and
flip angle, for MRI with fields of 0.5, 1, and 1.5 Tesla, used in the
method of Gandon et al from the University of Rennes, France (see
[24, 29])
0.5 T 1.0 T 1.5 T
TR TE Flip TR TE Flip TR TE Flip
120 14 90° 120 7 90° 120 4 90°
120 14 20° 120 7 20° 120 4 20°
120 28 20° 120 14 20° 120 9 20°
120 21 20° 120 14 20°
120 21 20°
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In the image analysis procedure, a critical aspect is the
choice of the decay model to be used for fitting the SI-time
curve. The single-exponential models used in earliest studies
[10] had some limitations and various other data-fitting
models have been proposed: single exponentials with
truncation or with progressively less weight is given to
weaker echoes, single-exponentials with a constant offset or
with subtraction of measured image noise, or bi-exponentials
[9, 11, 14, 19, 20]. Each model has advantages and
disadvantages, and consensus has not yet been reached on
which should be used. Further research is needed to identify
the most accurate model.
Another serious limitation of T2 and T2* relaxometry
methods is the limited access to the technique [15, 21–23].
New pulse sequences and software capable of generating
T2* images are not compatible with older hardware [22].
The number of machines capable of performing these
calculations automatically remains small. For example, the
MIOT (Myocardial Iron Overload in Thalassemia) network
in Italy, has grown since 2006 to reach 49 hematological or
pediatric centers specialised in thalassemia, but has only six
radiological centers with standardised MRI acquisition and
image processing protocols. These groups point out that
“MRI multi-echo T2* sequences able to quantify iron
overload are still non-commercial and their installation
requires the special involvement of the MRI scanner
vendor”. Moreover, they state that other MRI centers need
to be set up in the near future in order to “satisfy the
requests from thalassemia centers”; currently, in the exist-
ing network, the average distance between the clinical
centers and their corresponding radiological center is over
238 km [23].
There are now various types of post-processing solutions
on offer. In particular, St Pierre et al [8, 14] have developed
a service for calculating T2 (www.ferriscan.com) and the
method has been approved by the Food and Drug Adminis-
tration (FDA) in the USA. It requires previous external
validation with a phantom and the data analysis is centralised.
This involves an economic cost and takes two working days.
Commercial post-processing software, approved by the FDA,
is also available (CMR Tools, London, UK), but annual
licensing fees may be prohibitive for some institutions [22].
Fig. 5 MRI-estimated LIC ver-
sus biopsy-measured LIC in 174
patients by the method of
Gandon et al (see [24])
Table 2 Correlation between LIC values estimated by MRI using
the method of Gandon et al [24] and true LIC measured in
biopsies for three groups of patients with different levels of LIC
(normal <36 μmolFe/g; moderate iron overload :37–80 μmolFe/g;
high iron overload: >80 μmolFe/g) (see [24])
MRI Biopsy
Normal Moderate High
Normal 61 1 0 62
Moderate 42 20 2 64
High 4 17 24 45
107 38 26 171
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In summary, in 2011, T2 relaxometry methods are
already accurate and reproducible but are not yet stand-
ardised, nor are they widely available.
SIR methods
In this method, an indication of LIC is obtained by
calculating the ratio between the SI of the liver and the
SI in paraspinal muscle that does not accumulate iron.
The SI measurements are performed in the same slice
using large regions of interest (ROIs), and GRE
sequences are used due to their greater sensitivity to
the paramagnetic effect of iron. In order to be able to
quantify all levels of iron overload more than one
sequence are necessary [24–28].
The estimation of LIC by an SIR method is easier to
perform than T2 relaxometry. The most widely recognised
method is that developed by Gandon et al [24, 29] at the
University of Rennes, France. They have designed a set of
five breath-hold GRE sequences with fixed TR and
different TE and flip angles, optimised for 0.5, 1.0 and
1.5 Tesla (T) magnetic fields. The method can easily be
implemented by virtually all machines in the world
(Table 1). On each sequence, the liver the SI is measured
at three ROIs in the right lobe, while muscle SI is measured
at ROIs in the right and left paraspinal muscles.
Gandon et al [24] published a description of this method
in the Lancet in 2004. In a group of 139 patients, they
estimated the LIC with high accuracy, ranging from 3 to
375 μmol Fe/g (mean difference of 0.8 μmol Fe/g; 95%
confidence interval of 6.3–7.9). They validated the results
Fig. 6 MRI sequences of the method of Gandon et al in three
patients with different levels of LIC. a Patient without iron overload. b
Patient with moderate iron overload. c Patient with high iron overload.
d Scatterplots of L/M ratio and LIC for each MRI sequence. There is a
maximal decrease in liver SI with most T2-weighted sequences. SE
spin echo T1 sequence, PD proton density sequence (see [25])
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in a validation group of 35 patients (Fig. 5). The University
of Rennes has now provided a free online worksheet for
calculating LIC using this method [29]. By combining liver
and muscle (L/M) SIRs from the set of five sequences, it
automatically calculates an LIC value in μmol Fe/g.
This recommended protocol is in general use across the
world and many studies take the results obtained with it as
the reference value for LIC. Christoforidis et al [18],
compared the R2, R2* and values from the University of
Rennes model in a group of 94 patients with thalassemia.
The correlation between R2 and the Rennes values was
better than that between R2 and R2*.
The method does, however, have some limitations. It
saturates with very high iron overload and does not give a
value of LIC higher than 350 μmol Fe/g. It always
identifies these cases as very high iron overload (>350 μmol
Fe/g). Such patients always have a sufficiently high iron
overload to require treatment; nevertheless, not recognising
all the range of LIC values with clinical significance is a
limitation of the model. Specifically, many patients with
secondary haemochromatosis have LIC levels in this range.
Responding to this issue, a research group led by Rose et
al [30] from the University of Lille, France, has designed an
algorithm with two T1-weighted sequences for cases which
saturate at 350 μmol in the University of Rennes model,
significantly improving the correlation with the true LIC (R
=0.81). They designed a computer-based algorithm to
obtain the corresponding LIC automatically and have made
it available free of charge online (from: http://oernst.f51vg.
free.fr/liver/iron.html).
The protocol of the University of Rennes is now
widely used in clinical practice, despite the fact that
there has been relatively little research comparing the
results of this model to the “gold standard”, the LIC
measured by biochemical analysis of a liver biopsy. One
recently published study did compare the LIC quantified
by the University of Rennes model with the “gold
standard” in a group of 171 patients [31]. It was found
that the model correctly classified 105 (61%) of the
patients according to the various levels of iron overload
(normal <36 μmol Fe/g, moderate 37–79 μmol Fe/g and
high >79 μmol Fe/g) (Table 2) (r=0.87). A moderate
tendency to overestimate LIC was observed: 43% of
normal patients being classified as having iron overload
and 45% of the patients with moderate iron overload being
diagnosed with high iron overload; while very few
patients were underestimated. Cut-off points with high
predictive value (PV) for high iron overload diagnosis
were calculated: (1) >170 μmol Fe/g revealed a positive
PV of 100% (sensitivity 69%) and (2) <60 μmol Fe/g, a
negative PV of 100% (specificity 75%). With these cut-off
points, the model was reliable for ruling out or for
supporting high iron overload diagnosis in 127 (74%)
patients. For intermediate values, however, those between
60 and 170 μmol Fe/g, the diagnosis remained uncertain,
44 (26%) patients were in this group: 12 of these had
normal iron levels and eight high iron overload [31].
In addition, our working group, from 1999 to 2001,
compared the L/M ratio of all sequences of the method
from the University of Rennes to the LIC measured in
liver biopsies in 112 patients (Fig. 6). When linear
regression was performed between LIC and L/M ratios,
we observed that the T2 and proton density (PD)
sequences provided the best correlation. We created a
model to estimate LIC: LIC = e[5.808 - (0.877 × T2) - (1.518PD)]
where T2 and PD are the L/M ratios of these two
sequences respectively [PD 120 ms/4 ms/20° (TR/TE/flip
angle) and T2 120 ms/14 ms/20°] [25]. The correlation
with the true LIC for this model was very high (r=0.937)
(Fig. 7a), while in the same group of patients the
Fig. 7 MRI-estimated LIC versus biopsy-measured LIC in 112
patients. a By Osatek’s model (r=0.937). b By the model of Gandon
et al (r=0.887) (see [18])
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correlation with the model of the University of Rennes
was less strong (r=0.887) (Fig. 7b). We also calculated
cut-off points with high predictive value for high iron
overload. These were closer to true LIC values: 100%
positive PV for estimated LIC>85 μmol Fe/g (sensitivity
86%) and 100% negative PV for estimated value <40 μmol
Fe/g (specificity 75%) [25].
Our hospital is a referral center for a population of
400,000 and since 2002 we have processed more than 900
patients with alterations in iron metabolism. It requires a
straightforward test, with patients having to lie in the
machine for only 10 min. Then, with a simple Excel
worksheet, we automatically obtain the iron concentration
in micromoles [32].
Since 2007, we have had a multi-echo sequence to
calculate R2* (20 different echoes with TE ranging
between 1.1 and 19.1 s) (TR/TE/ΔTE/flip angle, 188 ms/
1.14 ms/0.9 ms/35°) (Fig. 2). We compared the LIC
estimated by the aforementioned SIR model and by R2*
in a group of patients, obtaining a good correlation between
the two values (r2=0.86). Currently, we are carrying out
studies using the SIR method, which has demonstrated a
high level of precision in clinical practice and provides us
with a meaningful LIC value in μmol Fe/g to include in
clinical reports. In parallel, we continue to use the multi-
echo sequence to measure T2* to assess iron concentration
in the myocardium.
In, summary, SIR methods are sufficiently accurate
for many cases in clinical practice and, what is more,
they are also reproducible, standardised and already
widely available.
Conclusion
T2 relaxometry is the best method to quantify LIC using
MRI. It is accurate and reproducible at all levels of iron
overload, and also allows myocardial iron concentration to
be measured. However, T2 relaxometry models are not yet
standardised and, in our opinion, there are considerable
barriers to them becoming widely available in the near
future. On the other hand, SIR methods, although they are
less accurate with values of LIC>350 μmol Fe/g, should
continue to be used since they have high specificity at all
levels of iron overload, they have been standardised, and
are reproducible and, moreover, they are already widely
available.
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